Rhythm Pharmaceuticals Inc (RYTM)
40.13
+0.26
(+0.65%)
USD |
NASDAQ |
Jun 27, 16:00
40.18
+0.05
(+0.12%)
After-Hours: 20:00
Rhythm Pharmaceuticals Net Income (Annual): -184.68M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -184.68M |
December 31, 2022 | -181.12M |
December 31, 2021 | -69.61M |
December 31, 2020 | -134.00M |
December 31, 2019 | -140.73M |
Date | Value |
---|---|
December 31, 2018 | -74.06M |
December 31, 2017 | -33.71M |
December 31, 2016 | -25.87M |
December 31, 2015 | -11.07M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-184.68M
Minimum
2023
-69.61M
Maximum
2021
-142.03M
Average
-140.73M
Median
2019
Net Income (Annual) Benchmarks
Pfizer Inc | 2.119B |
Amgen Inc | 6.717B |
Eli Lilly and Co | 5.240B |
Viking Therapeutics Inc | -85.90M |
Amicus Therapeutics Inc | -151.58M |